Vice President
ORIC Pharmaceuticals
Vice President
ORIC Pharmaceuticals
Clinical-stage oncology company targeting resistance
Preferred Experience:
The anticipated base salary for Vice President level candidates who will work on-site at our San Diego location is between $310,000-$385,000 per year. The final rate offered to a successful candidate will be dependent on several factors that may include, title, type and length of experience within the role, type and length of experience within the industry, education, geography, and other job-related factors. This position is not eligible for H-1B visa sponsorship.
ORIC Pharmaceuticals, Inc. is an equal opportunity employer. ORIC does not discriminate based on race, color, religion, gender, sexual orientation, gender identity, age, national origin, disability status, protected veteran status, or any other legally protected characteristics.
Salary Range : VP: $317K/$377K/$402K
Clinical-stage oncology company targeting resistance
ORIC Pharmaceuticals is a clinical-stage cancer company focused on overcoming how cancers resist treatment. Its therapies aim to restore patients’ response to existing treatments by targeting resistance mechanisms. Lead programs include rinzimetostat (ORIC-944), an allosteric inhibitor of the PRC2 complex designed for prostate cancer, and enozertinib (ORIC-114), a brain-penetrant inhibitor that targets EGFR exon 20 and HER2 exon 20 mutations in non-small cell lung cancer. Early work continues on other resistance mechanisms across solid tumors. Unlike some competitors, ORIC concentrates specifically on breaking or bypassing resistance to current therapies, based on research from Memorial Sloan Kettering Cancer Center and brought to Nasdaq-listed status in 2020. Its goal is to improve how well existing cancer treatments work for patients by keeping cancer from outsmarting them.
Explore more opportunities at ORIC Pharmaceuticals